Category: Uncategorized
ARCA BIOPHARMA ANNOUNCES THIRD QUARTER 2017 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE
Sidoti & Co. Fall 2017 Conference Announcement
ARCA biopharma Announces Completion of Enrollment for GENETIC-AF Phase 2B Clinical Trial
ARCA biopharma Announces GENETIC-AF Data and Safety Monitoring Board Recommendation to Complete Phase 2B GENETIC-AF Clinical Trial Based on Efficacy and Safety Data in Phase 2B Interim Analysis
ARCA biopharma Announces Second Quarter 2017 Financial Results and Provides Business Update
ARCA BIOPHARMA ANNOUNCES DATABASE LOCK FOR GENETIC-AF PHASE 2B INTERIM EFFICACY ANALYSIS – DSMB RECOMMENDATION ANTICIPATED IN AUGUST 2017
Equities.com Article – “ARCA biopharma (ABIO): Genetically Targeting Cardiovascular Disease”
https://www.equities.com/news/arca-biopharma-abio-genetically-targeting-cardiovascular-disease